Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

27.39
BATS BZX Real-Time Price
As of 12:28pm ET
 +0.36 / +1.33%
Today’s Change
9.89
Today|||52-Week Range
29.38
+87.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.2B

Company Description

Xencor, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. It uses proprietary XmAb technology platform to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, asthma, cancer, and other conditions. The company was founded Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Contact Information

Xencor, Inc.
111 West Lemon Avenue
Monrovia California 91016
P:(626) 305-5900
Investor Relations:
(626) 737-8013

Employees

Shareholders

Mutual fund holders45.43%
Individual stakeholders30.81%
Other institutional30.67%

Top Executives

Bassil I. DahiyatPresident, Chief Executive Officer & Director
John J. KuchVice President-Finance & Investor Relations
John R. DesjarlaisChief Scientific Officer & Senior VP-Research
Paul A. FosterChief Medical Officer
Lloyd A. RowlandSecretary, Chief Compliance Officer & Senior VP